| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8486530 | Vaccine | 2017 | 7 Pages |
Abstract
A booster dose of MCC was safe and induced high seroprotection rate even 12-18â¯months after priming. MCC should be administered after maximum virologic suppression has been achieved. These results support the recommendation of 2-dose of MCC for primary immunization in HIV-infected children and adolescents with restored immune function.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Ana Cristina C. Frota, Bianca Ferreira, Lee H. Harrison, Gisele S. Pereira, Wania Pereira-Manfro, Elizabeth S. Machado, Ricardo Hugo de Oliveira, Thalita F. Abreu, Lucimar G. Milagres, Cristina B. Hofer,